Get the Stockscreener App
77.86
2.89%
2.19
Pre-market:
77.80
-0.06
-0.08%
Genedx Holdings Corp Stock (WGS) Latest News
GeneDx (NASDAQ:WGS) Stock Price Down 5.6%Here's What Happened - MarketBeat
GeneDx Holdings Corp.'s (NASDAQ:WGS) large institutional owners must be happy as stock continues to impress, up 6.6% over the past week - Simply Wall St
WGSGeneDx Holdings Corp. Latest Stock News & Market Updates - StockTitan
GeneDx to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 18, 2025 - Business Wire
GeneDx Holdings Shares Surge Amid Mixed Signals - TipRanks
Nisa Investment Advisors LLC Acquires 50,009 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
309,500 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Bought by Zweig DiMenna Associates LLC - MarketBeat
GeneDx Holdings Corp. (NASDAQ:WGS) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
GeneDx Holdings Corp. (NASDAQ:WGS) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
GeneDx (NASDAQ:WGS) Shares Up 6%Here's What Happened - MarketBeat
GeneDx Holdings Corp. (NASDAQ:WGS) Shares Purchased by JPMorgan Chase & Co. - MarketBeat
Institutional owners may ignore GeneDx Holdings Corp.'s (NASDAQ:WGS) recent US$427m market cap decline as longer-term profits stay in the green - Yahoo Finance
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)January 17, 2025 - BioSpace
(WGS) Technical Data - Stock Traders Daily
Assenagon Asset Management S.A. Sells 61,642 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx (NASDAQ:WGS) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
GeneDx (NASDAQ:WGS) Trading Down 7.2%Here's What Happened - MarketBeat
Barclays PLC Acquires 14,681 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx Holdings: A Phenomenal Comeback With More Room To Run - Seeking Alpha
GeneDx raises Q4 adjusted gross margin view to 68% from 64% - Yahoo Finance
GeneDx Holdings (WGS) Surges 13.2%: Is This an Indication of Further Gains? - MSN
GeneDx anticipates higher-than-expected annual revenues - MSN
GeneDx Holdings Expects Strong 2024 Financial Performance - TipRanks
GeneDx forecasts strong revenue and gross margin growth By Investing.com - Investing.com South Africa
Why Have GeneDx Holdings Stocks Plummeted? - TipRanks
GeneDx forecasts strong revenue and gross margin growth - Investing.com India
GeneDx Announces Preliminary 2024 Financial Results - Business Wire
Insider Sell: Katherine Stueland Sells 51,420 Shares of GeneDx H - GuruFocus.com
Genedx CEO sells shares worth $4.86 million - Investing.com India
Genedx CEO sells shares worth $4.86 million By Investing.com - Investing.com Australia
GeneDx Holdings Corp. (NASDAQ:WGS) CFO Sells $3,331,172.92 in Stock - MarketBeat
GeneDx Holdings Corp. (NASDAQ:WGS) CEO Katherine Stueland Sells 51,420 Shares - MarketBeat
GeneDx (NASDAQ:WGS) Stock Price Down 6.3%What's Next? - MarketBeat
GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers - Business Wire
How the (WGS) price action is used to our Advantage - Stock Traders Daily
TD Cowen Boosts GeneDx (NASDAQ:WGS) Price Target to $118.00 - Defense World
GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients - Business Wire
GeneDx Holdings Corp. (NASDAQ:WGS) Looks Just Right With A 26% Price Jump - Simply Wall St
TD Cowen Forecasts Strong Price Appreciation for GeneDx (NASDAQ:WGS) Stock - MarketBeat
Genedx CEO Katherine Stueland sells shares worth $1.4 million By Investing.com - Investing.com Australia
GeneDx (NASDAQ:WGS) Hits New 52-Week HighShould You Buy? - MarketBeat
2025 investment picks - substack.com
GeneDx Holdings Corp. (NASDAQ:WGS) CEO Katherine Stueland Sells 18,006 Shares - MarketBeat
Kevin Feeley Sells 1,430 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) Stock - MarketBeat
Genedx CFO Kevin Feeley sells $108,736 in stock By Investing.com - Investing.com Australia
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):